Motor subtype changes in early Parkinson's disease
Introduction
It is widely accepted that Parkinson's disease (PD) is a clinically heterogeneous disease with several different motor phenotypes [1], [2]. Accurately characterizing the heterogeneity that occurs in PD is important for assessing prognosis, enrolling in clinical trials, and for screening for possible co-morbidities [3]. Properly subtyping patients is also a critical step for determining inclusion in both preclinical [4], [5] and clinical studies, particularly those involving individualized treatment plans based on motor symptoms [6], [7], [8].
PD subtype categories were originally based on clinical observation of motor symptoms [1], [9]. Commonly recognized subtypes of PD include a tremor dominant (TD) group and a postural instability and gait disorder/difficulty/dominant (PIGD) group [2]. Some clinicians and researchers also recognize an ill-defined intermediate or indeterminate type (IT) classification for patients that do not fit the TD or PIGD phenotype. Recently, studies have proposed additional subtypes based on data-driven cluster analysis approaches using other clinical characteristics including age of onset, speed of disease progression, cognitive measures, and behavioral measures [10], [11], [12], [13], [14]. Aside from establishing subtypes, several studies have attempted to clarify whether subtypes are fixed or whether they represent different stages of disease progression [15], [16].
In this study, our goal was to use a data-driven approach to discover distinct motor subtypes in PD, and to apply these subtypes to longitudinal motor assessment data to look for shift in category over time. To accomplish this task, we used hierarchical correlational clustering on motor assessment data from 423 early PD patients included in the Parkinson's Progression Markers Initiative (PPMI) database (www.ppmi-info.org/data).
Section snippets
Data source
Data used in this study were obtained from the Parkinson's Progression Markers Initiative (PPMI) database (www.ppmi-info.org/data). For up-to-date information on the study, visit www.ppmi-info.org. Further details on the PPMI project have been previously published [17]. The study was approved by the Institutional Review Board (IRB) at all participating institutions. The PPMI database offers unique access to longitudinal data from 423 early PD patients. Participants were required to enroll
Results
The number of total motor score assessments available in the PPMI database varies between 2 and 14 for each patient (M = 6.81, SD = 2.40). Follow-up visits for the sample as a whole occurred between 0 and 7.84 years after diagnosis (M = 1.63, SD = 1.46). The vast majority (96.4%) of time points were within 5 years of diagnosis. A total of 2866 motor score assessments were used for clustering, which resulted in three overall clusters: TD, IT, and PIGD. Within IT, three specific clusters emerged:
Discussion
Our results identified an additional AxD, ApD, and RD subtypes of PD, in addition to the previously reported TD, IT, and PIGD subtypes [2]. Our methods employed a novel, unsupervised machine learning approach to isolate different motor subtypes in newly diagnosed PD by using MDS-UPDRS motor assessment data. These results also suggested that early PD sub-classification was stable for some patients, but quite unstable for others. Around 60% of patients are classified as TD and 20% as PIGD within
Author roles
Research Project: Conception – RSE, KDF; Organization – RSE, CWH, DM-R; Execution – RSE.
Statistical Analysis: Design – RSE; Execution – RSE; Review and Critique – RSE, CWH, DM-R, LA, MSO, AG.
Manuscript: Writing of the First Draft – RSE; Review and Critique – RSE, CWH, DM-R, LA, MSO, AG.
Funding sources
This work was supported by the UF Pruitt Family Endowed Faculty Fellowship. PPMI – a public private partnership – is funded by the Michael J. Fox Foundation for Parkinson's Research (9558) and funding partners, including Abbvie, Avid Radiopharmaceuticals, Biogen, Bristol-Myers Squibb, Covance, GE Healthcare, Genentech, GlaxoSmithKline, Lilly, Lindbeck, Merck, Meso Scale Discovery, Pfizer, Piramal, Roche, Sanofi Genzyme, Servier, Teva, UCB, and Golub Capital.
Disclosures
R.S.E has no financial disclosures to report.
C.W.H. receives grant support from the University of Florida Clinical and Translational Research Institute, which is supported in part by NIH award KL2 TR001429. He has served as a research committee member for the Michael J. Fox Foundation and as a speaker for the National Parkinson Foundation, the Parkinson's Disease Foundation, and the Davis Phinney Foundation. Dr. Hess has participated in CME and educational activities on movement disorders
Acknowledgements
The authors thank the Michael J. Fox Foundation for Parkinson's Research for driving the PPMI development efforts, and all investigators that contributed to the database. We also thank Jackson Cagle, Stephanie Cernera, Enrico Opri, and Rene Molina for helpful discussion and feedback.
References (29)
- et al.
The association between motor subtypes and psychopathology in Parkinson's disease
Park. Relat. Disord.
(2009) - et al.
How stable are Parkinson's disease subtypes in de novo patients: analysis of the PPMI cohort?
Park. Relat. Disord.
(2016) - et al.
The heterogeneity of Parkinson's disease clinical and prognostic implications
Neurology
(1985) - et al.
The heterogeneity of idiopathic Parkinson's disease
J. Neurol.
(2002) - et al.
A clinico-pathological study of subtypes in Parkinson's disease
Brain
(2009) - et al.
Tremor dominant parkinsonism: clinical description and LRRK2 mutation screening
Mov. Disord.
(2008) - et al.
What genetics tells us about the causes and mechanisms of Parkinson's disease
Physiol. Rev.
(2011) - et al.
A personalized approach to Parkinson's disease patients based on founder mutation analysis
Front. Neurol.
(2016) - et al.
Tremor-predominant Parkinson's disease
Drugs & Aging
(2000) - et al.
Differential effects of deep brain stimulation target on motor subtypes in Parkinson's disease
Ann. Neurol.
(2015)
Variable expression of Parkinson's disease: a base-line analysis of the DATATOP cohort. the Parkinson study group
Neurology
Clinical heterogeneity in newly diagnosed Parkinson's disease
J. Neurol.
Heterogeneity of Parkinson's disease in the early clinical stages using a data driven approach
J. Neurology, Neurosurg. Psychiatry
A data-driven approach to the study of heterogeneity in idiopathic Parkinson's disease: identification of three distinct subtypes
Mov. Disord.
Cited by (32)
Early-onset Parkinson's disease: An assessment of unmet psychosocial needs
2023, Parkinsonism and Related DisordersEnhanced neuroimaging genetics using multi-view non-negative matrix factorization with sparsity and prior knowledge
2022, Medical Image AnalysisCitation Excerpt :Similar to other neurodegenerative diseases, PD also exhibits heterogeneous development and progression of various motor and non-motor symptoms (i.e., axial symptoms, cognitive impairment, speed of disease progression, etc.) (Rodríguez-Violante et al., 2017). To probe this heterogeneity in PD, many studies have attempted to divide PD into subgroups based on motor or non-motor symptoms, but currently, there is no consensus on how to do this (Eisinger et al., 2017; Mu et al., 2017; Sauerbier et al., 2016). Therefore, it is crucial to identify the complex mechanisms underlying PD.
The inconsistency and instability of Parkinson's disease motor subtypes
2021, Parkinsonism and Related DisordersParkinson's disease motor subtype changes during 20 years of follow-up
2020, Parkinsonism and Related DisordersCitation Excerpt :Large datasets with long-term follow-up are needed to ensure representative data that span the full spectrum of PD symptom heterogeneity. Despite vast differences in subtyping categories seen throughout the literature [16–19], an emerging consensus is the subtype designations for tremor dominant (TD) patients and postural instability and gait disorder/dominance (PIGD) as defined by motor assessment [8,16]. In this schema, individuals not fitting criteria for TD or PIGD are placed into an intermediate/indeterminate type (IT) category.
The late stage of Parkinson's –results of a large multinational study on motor and non-motor complications
2020, Parkinsonism and Related DisordersCitation Excerpt :Alternatively, some patients may not have received high enough doses of dopaminergic medications to develop dyskinesia, in agreement with previous findings in a study of Dutch nursing homes where many patients appeared to be relatively undertreated (3). Similarly, only 11% had moderate to severe tremor despite high overall motor scores, in keeping with the observations that many patients with the tremor subtype lose their tremor and develop the akinetic rigid subtype with longer follow-up [26,27]. It is also noteworthy that a proportion of 16.5% of patients had moderate to severe impulse control disorders, even in the advanced stages of the disease, indicating that these should be proactively screened for in this population, and not just in the higher risk group of younger men [28].
Young-onset Parkinson's disease: Its unique features and their impact on quality of life
2019, Parkinsonism and Related Disorders